Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/03/2014WO2014101115A1 Montelukast sodium tablet composition and preparation method thereof
07/03/2014WO2014101113A1 Piperazine-substituted 7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
07/03/2014WO2014101067A1 Hypoglycemic compound and preparation method thereof, pharmaceutical composition comprising the hypoglycemic compound, and application thereof
07/03/2014WO2014101038A1 Method for preparing drug-loaded microspheres
07/03/2014WO2014100934A1 Glycosidase inhibitors and uses thereof
07/03/2014WO2014100881A1 Compounds, use, reductase-inhibiting pharmaceutical composition in microorganisms, inha binder and method for obtaining inha binders
07/03/2014WO2014100852A1 Inhibition of cancer growth and metastasis
07/03/2014WO2014100851A1 Improved antimicrobial compositions
07/03/2014WO2014078688A3 Recombinant adenoviruses and use thereof
07/03/2014WO2014072961A3 Polymorphic forms of suvoroxant
07/03/2014WO2014067960A3 Functionalized 9-bromo-camptothecin derivatives
07/03/2014WO2014066502A3 Flavivirus protease inhibitors
07/03/2014WO2014059429A3 Small molecules inhibiting oncoprotein myc
07/03/2014WO2014055941A3 Compounds and methods for targeted immune system delivery
07/03/2014WO2014047562A3 Method of treating and/or preventing shingles and method of treating and/or preventing zoster associated pain
07/03/2014WO2014045307A3 Pharmaceutical composition
07/03/2014WO2014041088A3 Combined treatment with netrin-1 interfering drug and chemotherapeutic drug
07/03/2014WO2014018913A3 Santacruzamate a compositions and analogs and methods of use
07/03/2014WO2014015416A9 Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
07/03/2014WO2013189800A9 Cisatracurium and beta-cyclodextrin derivative compositions
07/03/2014WO2012100238A3 Compounds and methods for enhancing hair growth
07/03/2014US20140188056 Compositions and methods for transdermal delivery of non-steroidal anti-inflammatory agents
07/03/2014US20140187772 Pyrazole compounds useful as protein kinase inhibitors
07/03/2014US20140187648 Identifying Subjects in Need of Treatment
07/03/2014US20140187647 Methods of identifying subjects in need of treatment and methods of improving visual performance
07/03/2014US20140187646 Geranylgeranylacetone formulations and retinal and systemic delivery thereof
07/03/2014US20140187644 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
07/03/2014US20140187643 Method of Treatment with Anti-Inflammatory and Analgesic Compounds Which are GI-, Renal-, and Platelet-Sparing
07/03/2014US20140187642 Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide f2 alpha agonists
07/03/2014US20140187641 Estrogen receptor ligands and methods of use thereof
07/03/2014US20140187640 N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress
07/03/2014US20140187638 Phenylbutyrate in rectal form for the treatment of a motor neuron disease or a metabolic disease
07/03/2014US20140187635 Diclofenac compositions
07/03/2014US20140187634 Cure for edema of the foot and ankle
07/03/2014US20140187633 Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
07/03/2014US20140187632 Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
07/03/2014US20140187631 Methods for treating brain injury
07/03/2014US20140187629 Use of Bethanechol for Treatment of Xerostomia
07/03/2014US20140187628 Palatable suspending vehicle for pharmaceutical ingredients
07/03/2014US20140187627 Uses of c15-substituted andrographolide derivatives in the preparation of anti-hepatitis b virus medicament
07/03/2014US20140187624 Method of managing chemotherapy induced alopecia or cachexia or both
07/03/2014US20140187623 Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity
07/03/2014US20140187622 Composition comprising coumestrol or a bean extract containing coumestrol
07/03/2014US20140187621 Composition comprising coumestrol or a bean extract containing coumestrol
07/03/2014US20140187620 Composition comprising coumestrol or a bean extract containing coumestrol
07/03/2014US20140187619 Treatments for diabetes mellitus and obesity
07/03/2014US20140187618 Compositions, methods and kits using for inducing or enhancing neurogenesis in cells and tissue
07/03/2014US20140187611 Mitochondrial ribosomal proteins as aging regulators
07/03/2014US20140187605 Protection against endothelial barrier dysfunction through inhibition of the tyrosine kinase abl-related gene (arg)
07/03/2014US20140187601 Antisense oligonucleotide modulation of raf gene expression
07/03/2014US20140187599 Methods for treating diseases using isoindoline compounds
07/03/2014US20140187597 Pharmaceutical compositions for the treatment of movement disorders
07/03/2014US20140187595 Methods and Compositions Comprising AMPK Activator (Metformin/Troglitazone) for the Treatment of Myotonic Dystrophy Type 1 (DM1)
07/03/2014US20140187594 Diphenyl ether compounds for the treatment of liver, lung disorders, diabetic complications and cardiovascular diseases
07/03/2014US20140187593 Diagnostic test and treatment for a neurological disorder
07/03/2014US20140187582 Solid dispersions of amorphous paroxetine mesylate
07/03/2014US20140187580 Spin Traps and Spin Labels for the Treatment of Rectal Hemorrhoids
07/03/2014US20140187578 Pharmaceutical Topical Compositions
07/03/2014US20140187577 Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
07/03/2014US20140187576 Salt of naphthyridine carboxylic acid derivative
07/03/2014US20140187575 Lower dosage strength imiquimod formulations and short dosing regimens for treating genital and perianal warts
07/03/2014US20140187574 Use of rapamycin derivatives in vasculopathies and xenotransplantation
07/03/2014US20140187572 Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax
07/03/2014US20140187566 Pharmaceutical combination of mek inhibitor and b-raf inhibitors
07/03/2014US20140187563 Combination therapy in treatment of oncological and fibrotic diseases
07/03/2014US20140187560 Bromocriptine formulations
07/03/2014US20140187558 Preparation of sitagliptin intermediates
07/03/2014US20140187554 Modulators of the nuclear hormone receptor ror
07/03/2014US20140187552 Method of treatment of aggression
07/03/2014US20140187551 7-azaindole derivatives suitable for treatment of cancers
07/03/2014US20140187538 Lorcaserin hydrochloride
07/03/2014US20140187537 Methods of predicting outcomes of chemotherapy treatments and alternative therapies
07/03/2014US20140187530 AZA Spiro Alkane Derivatives as Inhibitors of Metalloproteases
07/03/2014US20140187528 Tazobactam arginine antibiotic compositions
07/03/2014US20140187525 Method for treating uterine fibroids
07/03/2014US20140187524 Treatment of Depressive Disorders
07/03/2014US20140187523 Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
07/03/2014US20140187522 Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism
07/03/2014US20140187520 Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof
07/03/2014US20140187518 Anti-itch scalp treatment compositions and combinations
07/03/2014US20140187517 Method for treating intestinal diseases presenting at least one inflammatory component
07/03/2014US20140187516 Dosage regimen of an s1p receptor modulator
07/03/2014US20140187514 Use Of Iron(III) Complex Compounds
07/03/2014US20140187513 Method of improving skills with a composition comprising non-digestible saccharide
07/03/2014US20140187512 Use of lactulose in the treatment of autism
07/03/2014US20140187511 Nucleoside phosphoramidate prodrugs
07/03/2014US20140187510 Molecular activators of the wnt/beta-catenin pathway
07/03/2014US20140187509 Use of s-adenosylmethionine, vitamin e, and vitamin c for the prevention and treatment of cardiovascular dysfunction
07/03/2014US20140187505 Cardiac Glycosides to Treat Cystic Fibrosis and Other IL-8 Dependent Disorders
07/03/2014US20140187504 Prevention and treatment of inflammatory conditions
07/03/2014US20140187501 Targeted Conjugates Encapsulated in Particles and Formulations Thereof
07/03/2014US20140187497 Ocular Drug Delivery Devices
07/03/2014US20140187495 Methods for treating glioblastoma
07/03/2014US20140187490 Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome
07/03/2014US20140187481 Transdermal Pharmaceutical Delivery Composition
07/03/2014US20140187480 Metabolic imprinting effects of specifically designed lipid component
07/03/2014US20140187470 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
07/03/2014US20140187441 Amplification of cyp24 and uses thereof
07/03/2014US20140186950 Synthetic membrane anchors
07/03/2014US20140186872 Bisacodyl and its analogues as drugs for use in the treatment of cancer
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 7860